We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > definitive agreement

News List

Dr. Reddy's enters into a definitive agreement to sell its neurology branded products to Upsher Smith Laboratories biospectrumasia
June 16, 2019
Under the agreement, Dr. Reddy’s will receive U.S.$70 million as upfront consideration, U.S.$40.5 million in near term milestones and additional financial considerations including existing contractual obligation and inventory.
Aposense has signed a definitive agreement with SirVir Ltd. A private company, jointly owned by Aposense, Prof. Roger D. Kornberg, and Access Industries Holdings LLC. firstwordpharma
January 10, 2019
Concurrently with the execution of the license agreement, a share purchase agreement was executed between the Company and Access whereby the latter will invest in the Subsidiary, in two stages, $ 20 million in return for preferred shares in the Subsidiary
Juniper Signs Definitive Agreement to be acquired by Catalent americanpharmaceuticalreview
July 11, 2018
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.